7575.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 07:35):

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan...

Stats
Dagens volum	130 100
Gjennomsnittsvolum	185 484
Markedsverdi	81.87B
EPS	¥0 ( 2024-02-01 )
Neste inntjeningsdato	( ¥0 ) 2024-06-27
Last Dividend	¥38.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	10.52
ATR14	¥0.830 (0.07%)

Volum Korrelasjon

Lang: -0.04 (neutral)

Kort: -0.57 (weak negative)

Signal:(40.012) Neutral

Japan Lifeline Co., Ltd. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Japan Lifeline Co., Ltd. Korrelasjon - Valuta/Råvare

-0.02
( neutral )

-0.15
( neutral )

-0.36
( neutral )

-0.40
( neutral )

-0.10
( neutral )

Japan Lifeline Co., Ltd. Økonomi

Annual	2022
Omsetning:	¥51.75B
Bruttogevinst:	¥29.90B (57.77 %)
EPS:	¥88.22

FY	2022
Omsetning:	¥51.75B
Bruttogevinst:	¥29.90B (57.77 %)
EPS:	¥88.22

FY	2022
Omsetning:	¥51.47B
Bruttogevinst:	¥28.84B (56.02 %)
EPS:	¥93.13

FY	2021
Omsetning:	¥51.29B
Bruttogevinst:	¥28.66B (55.89 %)
EPS:	¥24.91

Financial Reports:

No articles found.

Japan Lifeline Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥38.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Japan Lifeline Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.32 - Stable (13.64%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥3.13	2000-03-28
Last Dividend	¥38.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	22	--
Total Paid Out	¥232.75	--
Avg. Dividend % Per Year	0.00%	--
Score	3.18	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.32
Div. Directional Score	8.21	--

Next Divdend (Est)
(2025-05-26)

¥0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

3.18

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
4912.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
4072.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
3288.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2335.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9856.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8914.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
8020.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7270.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6505.T	Ex Dividend Junior	2024-05-30	Annually	0.00%
5715.T	Ex Dividend Junior	2024-03-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.165	1.500	6.71	10.00	[0 - 0.5]
returnOnAssetsTTM	0.121	1.200	5.97	7.16	[0 - 0.3]
returnOnEquityTTM	0.152	1.500	9.42	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.51	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.970	0.800	3.12	2.49	[0.8 - 2.5]
cashRatioTTM	0.907	1.500	6.07	9.11	[0.2 - 2]
debtRatioTTM	0.0591	-1.500	9.01	-10.00	[0 - 0.6]
interestCoverageTTM	405.57	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	34.12	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	34.12	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0729	-1.500	9.71	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.602	1.000	3.29	3.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.220	1.000	7.59	7.59	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.621	1.000	7.66	7.66	[0.2 - 2]
assetTurnoverTTM	0.734	0.800	8.44	6.75	[0.5 - 2]
Total Score				12.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.41	1.000	9.05	0	[1 - 100]
returnOnEquityTTM	0.152	2.50	9.63	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	34.12	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.59	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	34.12	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0380	1.500	-3.08	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0500	1.000	-1.250	0	[0.1 - 0.5]
Total Score				4.32

Japan Lifeline Co., Ltd.

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Sanntidsoppdatering for Japan Lifeline Co., Ltd. [7575.T]

Upcoming Earnings Alert

Japan Lifeline Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Commentary

Top 10 dividend Companies for JPX

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)